Start your 7-day free trial - Full platform access
Contract Review in Indianapolis

Contract review in Indianapolis.
Same day. No attorney needed.

Indianapolis attorneys charge $200-$400 per hour. Kontractually reviews the same contract in under 2 minutes - against your playbook, consistently, every time. Life sciences research agreements, pharma contracts, manufacturing, and vendor agreements.

No credit card required. First 3 reviews free.

Indianapolis vs Kontractually

Same contract review. A fraction of the attorney cost.

Local Attorney
  • $200-$400/hr billing rate
  • 3-5 business day turnaround
  • $500-$1,800 per NDA review
  • Inconsistent review standards
  • No playbook customization
Kontractually
  • Flat monthly subscription
  • Results in under 2 minutes
  • Unlimited reviews included
  • Same rules applied every time
  • Fully customizable playbooks
FAQ

Contract review questions for Indianapolis businesses.

More questions? Email us.

Indianapolis is a major life sciences hub with companies across pharmaceutical manufacturing, medical devices, and clinical research. Research agreements and CRO contracts in this sector carry specific IP and regulatory risk. Key issues include IP assignment clauses (ensuring the sponsor retains all rights to research outputs), material transfer agreements, publication rights and delay periods, data ownership, regulatory filing rights, and indemnification for regulatory failure. Kontractually reviews these against your playbook rules and flags missing IP assignments, ambiguous data ownership, and one-sided publication control provisions common in pharma research contracts.

Indianapolis attorneys typically charge $200-$400 per hour for commercial contract review. Life sciences and pharma specialists often charge at the higher end due to the regulatory complexity. A standard NDA review costs $400-$1,000; a research services agreement review costs $1,500-$5,000. Kontractually's flat monthly subscription covers unlimited reviews - useful for Indianapolis life sciences companies managing high volumes of CRO, CMO, supplier, and licensing agreements.

IP ownership in research agreements depends entirely on the contract language. Under Indiana law, IP created by an independent contractor belongs to the contractor unless there is a written assignment. For pharma and life sciences agreements, this means sponsor companies must include explicit assignment clauses covering all inventions, data, and research outputs arising from the engagement. Kontractually flags research agreements that lack assignment clauses, contain carve-outs for pre-existing IP that are too broad, or fail to cover improvements and derivative works.

Indiana enforces non-compete agreements under a reasonableness standard. Courts consider the geographic scope, duration, and scope of restricted activity. Indiana does not have a specific statute governing non-competes (unlike some other states), so enforceability depends on common law reasonableness factors. For pharma and life sciences, non-competes are particularly sensitive because they can restrict access to specialized research talent. Kontractually reviews non-compete clauses against your configured rules, flagging excessive duration, undefined geographic scope, and missing consideration for employees asked to sign new restrictions after commencing employment.

Review every contract before you sign. No attorney required.

Set up your playbook in 10 minutes. First 3 reviews free. No credit card required.

Start free trial